Alife’s AI Technology Now Available on Hamilton Thorne Laser Systems
The partnership between Hamilton Thorne, Inc. & Alife Health aims to expand access to cutting-edge AI technology to support clinical decision making
Alife Health, the leading technology company building AI tools to advance in-vitro fertilization (IVF) in the US today, announced a marketing partnership with Hamilton Thorne, Inc., which manufactures and markets precision laser systems, imaging systems, consumables, and services that enable breakthroughs in Assisted Reproductive Technologies (ART) and Developmental Biology Research markets.
Through this partnership, Alife’s Embryo Assist software will be available on Hamilton Thorne laser systems to enable embryologists to seamlessly create digital records of every embryo as well as leverage Alife’s Clinical Decision Support (CDS) algorithm to determine the best embryo for transfer. As part of the partnership, all US-based Hamilton Thorne clients will receive a three month trial of the Embryo Assist technology.
Catherine Welch, VP of Clinical Sales & Customer Success (Americas) for Hamilton Thorne, says:
Hamilton Thorne is dedicated to leveraging cutting-edge industry expertise to continually enhance our comprehensive suite of products and services.
“We prioritize partnerships with forward-thinking companies and top industry experts to collaborate on ways to expand customer-centric solutions that bring innovations to life.”
The Embryo Assist software is a microscope-integrated tool, allowing embryologists to easily capture embryo images and data to elevate laboratory quality-control measures. The software also boasts a CDS-based AI embryo ranking feature, which utilizes machine learning to help embryologists determine which embryos have the highest likelihood of success. Alife’s award-nominated scientific abstract regarding the CDS model, demonstrates non-inferior performance to manual embryo grading by highly experienced embryologists. This indicates the tool can offer laboratories a new level of standardization for embryo selection.
“At Alife, we value the opportunity to partner with industry leaders with a demonstrated history of excellence in reproductive medicine,” says Melissa Teran, COO and Head of Product for Alife Health.
We are thrilled to partner with Hamilton Thorne to advance our mutual goal of using technology to provide the most effective care for individuals seeking to grow their family.
Alife’s AI Technology Now Available on Hamilton Thorne Laser Systems, source.
Read the lates AI news at thinkaivolution.
